Retained earnings 37,685,487 25,206,169
Total Stockholders' Equity 64,483,411 39,761,358
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY $66,824,681 $43,706,320 CHINA PHARMA HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (unaudited)
For the three months For the nine months
ended September 30, ended September 30,
2008 2007 2008 2007
Revenue $12,610,642 $8,293,497 $35,606,490 $24,097,521
Cost of revenue 6,494,266 4,413,052 17,730,026 13,018,566
Gross profit 6,116,376 3,880,445 17,876,464 11,078,955
Operating expenses:
Selling expenses 529,432 591,193 1,323,854 896,128
General and
administrative 427,399 328,743 1,226,888 927,162
Research and
development 5,581 5,941 42,807 5,942
Bad debt expense, net
of recoveries 459,500 (169,095) 1,539,313 910,718
Total operating
expenses 1,421,912 756,782 4,132,862 2,739,950
Income from operations 4,694,464 3,123,663 13,743,602 8,339,005
Non-operating income
(expenses):
Interest income 26,224 4,400 31,259 29,808
Interest expense (34,629) (50,857) (130,342) (166,698)
Other (expense) income (9,588) 7,549 (87,038) 582,827
Total non-operating
income (expense) (17,993) (38,908) (186,121) 445,937
Income before taxes 4,676,471 3,084,755 13,557,481 8,784,942
Income tax expense
'/>"/>
| SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |